Håvard Midgard retweeted
What a concept! Starting treatment for people with chronic but curable infections in the hospital. Too bad most insurers and @MedicareGov won’t cover such out-patient issues.
✨️OPPORTUNI-C✨️
🆕️✨️Stepped wedge cluster randomized trial @CIDJournal
Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs #idxposts #MedEd academic.oup.com/cid/article…
Håvard Midgard retweeted
Inspiring work by inspiring people @Ane_Kristine @HMidgard @selihep - It's time to stop writing "hcv, defer to outpatient" in your consult notes, #idtwitter
Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure.
Results argue for broader use. @HMidgard @selihep doi.org/10.1093/cid/ciad711
Håvard Midgard retweeted
Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial
✅ Just Accepted
🔓 Open Access
🔗 bit.ly/40YwC17
via @HMidgard @selihep
Håvard Midgard retweeted
Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure.
Results argue for broader use. @HMidgard @selihep doi.org/10.1093/cid/ciad711
Håvard Midgard retweeted
Don’t put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C
✅ Just Accepted
💬 Editorial Commentary
🔗 bit.ly/47nNWip
Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial academic.oup.com/cid/article…
Håvard Midgard retweeted
Last session @INHepSU and grateful that the main result from Opportuni-C was highlighted in @tdbrothers rapporteur! @HMidgard
Håvard Midgard retweeted
Take home message from Kristian Malme today @INHepSU: Although HCV treatment uptake increased among people who inject drugs in 🇳🇴, strategies to improve treatment among women and individuals not engaged in OAT should be addressed!
Håvard Midgard retweeted
Practice changing findings ALERT: from OPPORTUNI-C in Norway, a pragmatic RCT showing inpatient initiation of HCV rx is doable, safe, and WORKS...even in a pandemic. A tour de force from @HMidgard @Ane_Kristine @selihep at #INHSU2022
Håvard Midgard retweeted
At #INHSU2021 session #Innovations in HepC Testing and Treatment @HMidgard presented live #peer #mobile #HCVclinic.
Håvard Midgard retweeted
Replying to @HMidgard
@HMidgard How can we achieve WHO's elimination target for hepatitis C incidence? thelancet.com/journals/langa…
Håvard Midgard retweeted
We @WHO just released a new report on #hepatitis C treatment. It shows the annual number of people initiating HCV curative treatment increased from 1 mln in 2015 to 1.5 mln in 2016. But access is focused primarily in a few high-burden countries. https://xitter.gq/t.co/V6q8eqgvRh #NOHEP
Håvard Midgard retweeted
«The times they are a’changin’» – Positioning @EASLnews in the changing landscape of hepatology
https://xitter.gq/t.co/6cWe3Hkk2u
@tomhemmingk
Håvard Midgard retweeted
#EASLmono conf on elimination of #hepatitisC infection was a great success, watch the webcasts & ePosters on #EASL #LiverTree
https://xitter.gq/t.co/FFr4GfygCL #HCV #publichealth #testing #treatment #epidemiology @EASLnews @JVLazarus @JMPawlotsky @aelsharkawy75 @AghemoAlessio
Håvard Midgard retweeted
He did a great job. Thank you @jasongrebely @martinkaberg for the video greetings. His work will be the foundations for NO #hepc strategy xitter.gq/oevrehusdk/status/9640… – at Oslo, Norway
Håvard Midgard retweeted
Scale-up of #HCV #treatment and other interventions is needed to minimise #hepatitisC transmission in #PWID in #Europe
https://xitter.gq/t.co/oVlOyqUkRS
#openaccess #hepc #Hepatitis
@EASLEUAffairs
Håvard Midgard retweeted
Very proud to see my mentor, collaborator, and friend @GregDore2 @KirbyInstitute recognised by @LancetGastroHep for his leadership in advancing #HCV therapeutics, care for #PWID and elimination efforts - Congrats and well-deserved! thelancet.com/journals/langa…
Håvard Midgard retweeted
New: Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial - thelancet.com/journals/langa…
#hepC #nohep #harmreduction @jasongrebely































